Immunotherapy in Cancer Treatment


Immunotherapy research aligns with the broader trend in the biotechnology and healthcare industry towards developing innovative treatments that harness the body’s immune system to fight cancer. Immunotherapies are gaining traction as a promising approach to cancer treatment.


MimiVax’s development of SurVaxM for glioblastoma (ndGBM) highlights the trend of biotechnology companies targeting rare or difficult-to-treat cancers. The industry is increasingly recognizing the need for specialized therapies to address specific types of cancers and improve treatment outcomes. 77 million funding.



Related Trends